Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983;25(5):651-5.
doi: 10.1007/BF00542354.

Single and repeated dose kinetics of the hypnotic agent loprazolam in healthy volunteers

Single and repeated dose kinetics of the hypnotic agent loprazolam in healthy volunteers

L A Stevens et al. Eur J Clin Pharmacol. 1983.

Abstract

The pharmacokinetics of loprazolam have been studied in eight healthy male volunteers after single and repeated 2 mg oral doses taken at night, for eight nights. The absorption and disposition of unchanged drug (HPLC-GC assay) and receptor active benzodiazepine-type materials (radioreceptor assay) were examined after the first and eighth dose. Maximum levels of approximately 10 ng ml-1 (range 3.6 to 15.5 ng ml-1) were reached within about 2.5 h after dosing. The post-peak levels declined in a single exponential fashion with an overall mean +/- SD half-life of 7.06 +/- 1.98 h and total areas under the curve ranging from 35.9 to 189.0 ng ml-1 h. There were no statistical differences between the values for the first and eighth doses. There was no evidence to suggest that significant accumulation of parent drug or receptor active benzodiazepine-type materials had occurred, and it is concluded that the kinetics of loprazolam would allow repeated daily doses of 2 mg.

PubMed Disclaimer

References

    1. Br J Clin Pharmacol. 1981;11 Suppl 1:61S-69S - PubMed
    1. J Pharm Pharmacol. 1979 Jul;31(7):448-51 - PubMed
    1. J Pharm Pharmacol. 1976 Apr;28(4):312-3 - PubMed
    1. Br J Clin Pharmacol. 1981;11 Suppl 1:11S-16S - PubMed
    1. Br J Clin Pharmacol. 1981;11 Suppl 1:31S-35S - PubMed

LinkOut - more resources